• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青蒿素及其衍生物:从分子机制到临床应用——抗疟之外的新视野

Artemisinin and Its Derivatives from Molecular Mechanisms to Clinical Applications: New Horizons Beyond Antimalarials.

作者信息

Xia Yi, Shi Chuanjing, Lu Jingze, Zhu Zeyu, Li Mohan, Pan Yinan, Huang Xinyan, Zhang Lei, Liu Aifen

机构信息

Institute of Interdisciplinary Integrative Medicine Research, School of Medicine, Nantong University, Nantong 226001, China.

Department of Pharmaceutical Botany, School of Pharmacy, Naval Medical University, Shanghai 200433, China.

出版信息

Int J Mol Sci. 2025 Aug 29;26(17):8409. doi: 10.3390/ijms26178409.

DOI:10.3390/ijms26178409
PMID:40943352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12429344/
Abstract

Artemisinin and its derivatives are widely recognized for their exceptional antimalarial efficacy. Recently, accumulating evidence indicates therapeutic potential beyond malaria. Despite these advances, detailed mechanisms and pharmacological limitations remain incompletely defined. This review summarizes their pharmacological activities and molecular mechanisms associated with oncology, immunoregulation, and metabolic disorders. Mechanistically, these compounds exert potent antitumor effects by inducing oxidative stress, arresting the cell cycle, triggering apoptosis, and inhibiting angiogenesis. They likewise modulate immune responses, re-establishing immune homeostasis and enhancing the effectiveness of immunotherapeutic strategies. Preliminary evidence also suggests involvement in metabolic regulation, pointing to promising avenues for treating metabolic disorders. Given alternative mechanisms of artemisinin and its derivatives, we also discuss the trinity modulation network among antitumor activity, immunoregulation, and metabolic homeostasis. We anticipate that future research will address these knowledge gaps, thereby enhancing the clinical utility of artemisinin and its derivatives and improving patient outcomes across diverse pathologies.

摘要

青蒿素及其衍生物因其卓越的抗疟功效而广受认可。最近,越来越多的证据表明其在疟疾之外具有治疗潜力。尽管有这些进展,但详细的机制和药理学局限性仍未完全明确。本综述总结了它们与肿瘤学、免疫调节和代谢紊乱相关的药理活性和分子机制。从机制上讲,这些化合物通过诱导氧化应激、阻滞细胞周期、触发细胞凋亡和抑制血管生成发挥强大的抗肿瘤作用。它们同样调节免疫反应,重新建立免疫稳态并增强免疫治疗策略的有效性。初步证据还表明其参与代谢调节,为治疗代谢紊乱指明了有前景的途径。鉴于青蒿素及其衍生物的其他作用机制,我们还讨论了抗肿瘤活性、免疫调节和代谢稳态之间的三位一体调节网络。我们预计未来的研究将填补这些知识空白,从而提高青蒿素及其衍生物的临床效用,并改善各种病症患者的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858b/12429344/54718419aa42/ijms-26-08409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858b/12429344/17e086879269/ijms-26-08409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858b/12429344/de0f55c795d0/ijms-26-08409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858b/12429344/e78dd1093162/ijms-26-08409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858b/12429344/54718419aa42/ijms-26-08409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858b/12429344/17e086879269/ijms-26-08409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858b/12429344/de0f55c795d0/ijms-26-08409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858b/12429344/e78dd1093162/ijms-26-08409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858b/12429344/54718419aa42/ijms-26-08409-g004.jpg

相似文献

1
Artemisinin and Its Derivatives from Molecular Mechanisms to Clinical Applications: New Horizons Beyond Antimalarials.青蒿素及其衍生物:从分子机制到临床应用——抗疟之外的新视野
Int J Mol Sci. 2025 Aug 29;26(17):8409. doi: 10.3390/ijms26178409.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
ER Stress Induced by Artemisinin and Its Derivatives Determines the Susceptibility to Their Synergistic Apoptotic Killing With TRAIL.青蒿素及其衍生物诱导的内质网应激决定了它们与TRAIL协同凋亡杀伤的敏感性。
Cancer Med. 2025 Jun;14(12):e71001. doi: 10.1002/cam4.71001.
4
Subsidising artemisinin-based combination therapy in the private retail sector.对私营零售部门基于青蒿素的联合疗法进行补贴。
Cochrane Database Syst Rev. 2016 Mar 9;3(3):CD009926. doi: 10.1002/14651858.CD009926.pub2.
5
Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence.青蒿素衍生物治疗疟疾相关的溶血反应:当前证据的系统评价
Int J Infect Dis. 2014 Dec;29:268-73. doi: 10.1016/j.ijid.2014.09.007. Epub 2014 Nov 1.
6
Computational Analysis of Plasmodium falciparum DNA Damage Inducible Protein 1 (PfDdi1): Insights into Binding of Artemisinin and its Derivatives and Implications for Antimalarial Drug Design.恶性疟原虫DNA损伤诱导蛋白1(PfDdi1)的计算分析:青蒿素及其衍生物结合情况的深入研究及对抗疟药物设计的启示
Cell Biochem Biophys. 2025 Mar 20. doi: 10.1007/s12013-025-01709-2.
7
Artemisinin derivatives for treating uncomplicated malaria.用于治疗非复杂性疟疾的青蒿素衍生物。
Cochrane Database Syst Rev. 2000;1999(2):CD000256. doi: 10.1002/14651858.CD000256.
8
Preclinical Evaluation of Repurposed Antimalarial Artemisinins for the Treatment of Malignant Peripheral Nerve Sheath Tumors.用于治疗恶性外周神经鞘瘤的青蒿素类抗疟药的临床前评估
Int J Mol Sci. 2025 Jul 10;26(14):6628. doi: 10.3390/ijms26146628.
9
Artemisiae Annuae Herba: from anti-malarial legacy to emerging anti-cancer potential.青蒿:从抗疟传统到新出现的抗癌潜力
Theranostics. 2025 Jun 20;15(15):7346-7377. doi: 10.7150/thno.115414. eCollection 2025.
10
Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria.青蒿素-萘酚喹治疗非复杂性恶性疟原虫疟疾
Cochrane Database Syst Rev. 2015 Feb 23;2015(2):CD011547. doi: 10.1002/14651858.CD011547.

本文引用的文献

1
Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis.青蒿素在自身免疫性疾病中的作用:系统性红斑狼疮和类风湿关节炎中的效应与机制
Br J Pharmacol. 2025 Aug;182(15):3411-3427. doi: 10.1111/bph.70086. Epub 2025 Jun 5.
2
Mitochondrial Reactive Oxygen Species (mROS) Generation and Cancer: .线粒体活性氧(mROS)的产生与癌症:.
Int J Nanomedicine. 2025 May 13;20:6085-6119. doi: 10.2147/IJN.S510972. eCollection 2025.
3
Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya.
肯尼亚女性阴道内自行给药青蒿琥酯阴道栓的药代动力学I期研究。
PLoS One. 2025 Apr 9;20(4):e0316334. doi: 10.1371/journal.pone.0316334. eCollection 2025.
4
Clinical development of immuno-oncology therapeutics.免疫肿瘤治疗药物的临床开发
Cancer Lett. 2025 May 1;617:217616. doi: 10.1016/j.canlet.2025.217616. Epub 2025 Mar 6.
5
Dihydroartemisinin inhibits the development of autoimmune thyroiditis by modulating oxidative stress and immune imbalance.双氢青蒿素通过调节氧化应激和免疫失衡来抑制自身免疫性甲状腺炎的发展。
Free Radic Biol Med. 2025 Apr;231:57-67. doi: 10.1016/j.freeradbiomed.2025.02.028. Epub 2025 Feb 21.
6
Oral glucose-responsive nanoparticles loaded with artemisinin induce pancreatic β-cell regeneration for the treatment of type 2 diabetes.负载青蒿素的口服葡萄糖响应性纳米颗粒可诱导胰腺β细胞再生以治疗2型糖尿病。
J Colloid Interface Sci. 2025 Apr 15;684(Pt 1):769-782. doi: 10.1016/j.jcis.2025.01.051. Epub 2025 Jan 9.
7
Artemisinin protected human bronchial epithelial cells from amiodarone-induced oxidative damage via 5'-AMP-activated protein kinase (AMPK) activation.青蒿素通过激活5'-AMP激活蛋白激酶(AMPK)保护人支气管上皮细胞免受胺碘酮诱导的氧化损伤。
Redox Rep. 2025 Dec;30(1):2447721. doi: 10.1080/13510002.2024.2447721. Epub 2025 Jan 13.
8
Network pharmacological mechanism and molecular experimental validation of artemisinin in the treatment of lung adenocarcinoma.青蒿素治疗肺腺癌的网络药理学机制及分子实验验证
Toxicol Appl Pharmacol. 2025 Feb;495:117226. doi: 10.1016/j.taap.2025.117226. Epub 2025 Jan 6.
9
Oral delivery of dihydroartemisinin for the treatment of melanoma via bovine milk exosomes.通过牛乳外泌体口服双氢青蒿素治疗黑色素瘤
Drug Deliv Transl Res. 2025 Jan 7. doi: 10.1007/s13346-024-01785-6.
10
Artemisinin Suppressed Melanoma Recurrence and Metastasis after Radical Surgery through the KIT/PI3K/AKT Pathway.青蒿素通过KIT/PI3K/AKT通路抑制根治性手术后黑色素瘤的复发和转移。
Int J Biol Sci. 2025 Jan 1;21(1):75-94. doi: 10.7150/ijbs.97341. eCollection 2025.